SenzaGen AB (STO:SENZA)
4.790
+0.010 (0.21%)
May 15, 2025, 5:29 PM CET
SenzaGen AB Revenue
SenzaGen AB had revenue of 13.66M SEK in the quarter ending March 31, 2025, a decrease of -4.74%. This brings the company's revenue in the last twelve months to 57.02M, up 9.82% year-over-year. In the year 2024, SenzaGen AB had annual revenue of 57.70M with 15.69% growth.
Revenue (ttm)
57.02M
Revenue Growth
+9.82%
P/S Ratio
2.47
Revenue / Employee
1.68M
Employees
34
Market Cap
141.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57.70M | 7.83M | 15.69% |
Dec 31, 2023 | 49.87M | 8.10M | 19.39% |
Dec 31, 2022 | 41.77M | 26.35M | 170.85% |
Dec 31, 2021 | 15.42M | 7.46M | 93.79% |
Dec 31, 2020 | 7.96M | 5.23M | 192.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Camurus AB | 2.04B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vitrolife AB | 3.61B |
Vimian Group AB | 4.24B |